Related Experiment Videos
Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity
Insights
Severe childhood autosomal recessive muscular dystrophy (SCARMD) involves muscle adhalin deficiency. This study identifies new adhalin gene mutations, revealing primary adhalinopathies as a key cause of this Duchenne-like muscular dystrophy.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Severe childhood autosomal recessive muscular dystrophy (SCARMD) is characterized by a deficiency in muscle adhalin, a sarcolemmal dystrophin-associated glycoprotein.
- This Duchenne-like myopathy affects both sexes and has been observed in diverse populations worldwide.
- Previous studies linked SCARMD to chromosome 13 defects or mutations in the adhalin gene on chromosome 17q.
Purpose of the Study:
- To investigate the prevalence and significance of primary adhalinopathies in muscular dystrophies with adhalin deficiency.
- To identify and characterize novel mutations within the adhalin gene in affected families.
Main Methods:
- Genetic analysis of 10 new families from Europe and North Africa.
- Identification and characterization of both null and missense mutations in the adhalin gene.
- Correlation of genotype with clinical phenotypes, including age of onset and disease progression.
Main Results:
- Several new mutations (null and missense) in the adhalin gene were identified in 10 families with adhalin deficiency.
- Primary adhalinopathies, caused by direct adhalin gene defects, were confirmed as a significant cause of SCARMD.
- Disease severity, characterized by age of onset and progression rate, was found to be most pronounced in patients with null mutations in the adhalin gene.
Conclusions:
- Primary adhalinopathies represent a crucial subgroup of muscular dystrophies characterized by adhalin deficiency.
- The identified mutations expand the spectrum of genetic defects leading to SCARMD.
- Adhalin gene mutations, particularly null mutations, are strongly associated with severe clinical manifestations of this muscular dystrophy.
Abstract:
Marked deficiency of muscle adhalin, a 50 kDa sarcolemmal dystrophin-associated glycoprotein, has been reported in severe childhood autosomal recessive muscular dystrophy (SCARMD). This is a Duchenne-like disease affecting both males and females first described in Tunisian families. Adhalin deficiency has been found in SCARMD patients from North Africa Europe, Brazil, Japan and North America (SLR & KPC, unpublished data). The disease was initially linked to an unidentified gene on chromosome 13 in families from North Africa, and to the adhalin gene itself on chromosome 17q in one French family in which missense mutations were identified. Thus there are two kinds of myopathies with adhalin deficiency: one with a primary defect of adhalin (primary adhalinopathies), and one in which absence of adhalin is secondary to a separate gene defect on chromosome 13. We have examined the importance of primary adhalinopathies among myopathies with adhalin deficiency, and describe several additional mutations (null and missense) in the adhalin gene in 10 new families from Europe and North Africa. Disease severity varies in age of onset and rate of progression, and patients with null mutations are the most severely affected.